Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral minoxidil versus oral finasteride for androgenetic alopecia
ACTRN12625001306404Phase 3Recruiting
- Sponsor
- PNS Shifa
- Start
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in androgenetic alopecia (AGA) comparing Oral minoxidil with Oral finasteride (2 arms). Primary endpoints: Photographic score, Terminal and vellus hair counts and 1 more. Started Nov 2025; status: recruiting.
02
Drugs
minoxidilfinasteride
03
Conditions
androgenetic alopecia (AGA)
Beyond the preview
Go deeper on ACTRN12625001306404.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12625001306404.